2 Reasons CNS is risky and 1 stock to buy instead Cohen & Steers has been treading water for the past six months, recording a small return of 4.2% while holding steady at $71. Is there a buying opportunity in Cohen & Steers, or does it present a risk to your portfolio? Dive into our full research report to see our analyst team's opinion, it's free. Why do we think Cohen & Steers will underperform? We're sitting this one out for now. Here are two reasons why CNS doesn't excite us, plus one stock we'd rather own. 1. Long-term revenue growth disappoints A company's long-term sales performance is one signal of its overall quality. Any business can have short-term success, but a top-tier one grows for years.
Головну думку ми показуємо публічно. Створіть безкоштовний акаунт, щоб читати повну статтю, зберігати її, обговорювати та поєднувати з ринковим і OSINT-контекстом.